Study record · GHK-Cu
Randomized study of tripeptide-copper complex cream in venous stasis ulcers
The copper-tripeptide cream did not differ significantly from vehicle placebo; silver sulfadiazine reduced ulcer size.
Key result
The copper-tripeptide cream did not differ significantly from vehicle placebo; silver sulfadiazine reduced ulcer size.
Study details
Study designRandomized controlled topical trial
PhaseClinical
PopulationPatients with venous stasis ulcers
Sample size86
RouteTopical
Regimen / exposure0.4% tripeptide-copper complex cream
DurationStudy course per protocol
ComparatorVehicle placebo and silver sulfadiazine
Primary endpoint / questionUlcer healing / size reduction
Safety resultNo major unique safety conclusion supports injectable use.
Key limitationsOlder topical wound study; formulation and indication differ from cosmetic/injectable claims.
Registry / identifierPMID 1495150